Sanofi Settles Obesity Drug Class Action For $40M

Law360, Los Angeles (September 19, 2013, 9:17 PM ET) -- French pharmaceutical giant Sanofi-Aventis SA has agreed to pay $40 million to settle a class action brought by investors who claim the company withheld information about anti-obesity drug Zimulti's link to severe psychiatric problems, according to documents filed in New York federal court on Thursday.

The agreement, which still requires court approval, comes six months after a New York federal judge certified the class of investors, finding the lead plaintiffs’ securities fraud claims were typical of the class as a whole.

U.S. District Judge George B....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In re: sanofi-aventis Securities Litigation


Case Number

1:07-cv-10279

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

George B. Daniels

Date Filed

November 13, 2007

Law Firms

Companies

Government Agencies